Page last updated: 2024-08-25

oxazolidin-2-one and oritavancin

oxazolidin-2-one has been researched along with oritavancin in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (70.00)29.6817
2010's3 (30.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ballow, CH; Bhavnani, SM1
Sharpe, JN1
Eliopoulos, GM1
Anstead, GM; Owens, AD1
de Roux, A; Lode, H; Schmidt-Ioanas, M1
Loffler, CA; Macdougall, C1
Arhin, FF; Belley, A; McKay, GA; Moeck, G; Neesham-Grenon, E; Parr, TR1
Arhin, FF; Moeck, G; Sarmiento, I1
Holmes, NE; Howden, BP1
Concia, E; Falcone, M; Giusti, M; Mazzone, A; Santini, C; Stefani, S; Violi, F1

Reviews

5 review(s) available for oxazolidin-2-one and oritavancin

ArticleYear
New agents for Gram-positive bacteria.
    Current opinion in microbiology, 2000, Volume: 3, Issue:5

    Topics: Acetamides; Anti-Bacterial Agents; Clinical Trials as Topic; Drug Approval; Fluoroquinolones; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Linezolid; Lipoglycopeptides; Oxazolidinones; Virginiamycin

2000
Recent advances in the treatment of infections due to resistant Staphylococcus aureus.
    Current opinion in infectious diseases, 2004, Volume: 17, Issue:6

    Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Multiple, Bacterial; Glycopeptides; Humans; Linezolid; Lipoglycopeptides; Minocycline; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tigecycline; Virginiamycin

2004
New antibiotics for the treatment of severe staphylococcal infection in the critically ill patient.
    Current opinion in critical care, 2005, Volume: 11, Issue:5

    Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Clinical Trials as Topic; Critical Illness; Daptomycin; Drug Resistance, Multiple, Bacterial; Glycopeptides; Humans; Linezolid; Lipoglycopeptides; Methicillin Resistance; Minocycline; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tigecycline; Virginiamycin

2005
What's new in the treatment of serious MRSA infection?
    Current opinion in infectious diseases, 2014, Volume: 27, Issue:6

    Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Cost-Benefit Analysis; Drug Administration Routes; Drug Therapy, Combination; Glycopeptides; Humans; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Severity of Illness Index; Skin Diseases, Bacterial; Staphylococcal Infections; Tetrazoles; Vancomycin

2014
Acute bacterial skin and skin structure infections in internal medicine wards: old and new drugs.
    Internal and emergency medicine, 2016, Volume: 11, Issue:5

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Ceftaroline; Cephalosporins; Daptomycin; Female; Fluoroquinolones; Glycopeptides; Hospitalization; Humans; Iatrogenic Disease; Internal Medicine; Linezolid; Lipoglycopeptides; Male; Minocycline; Oxazolidinones; Skin Diseases, Infectious; Soft Tissue Infections; Teicoplanin; Tigecycline; Vancomycin

2016

Other Studies

5 other study(ies) available for oxazolidin-2-one and oritavancin

ArticleYear
Antibiotics as an adjunct to surgical management of lower extremity ulcerations.
    Microsurgery, 2004, Volume: 24, Issue:1

    Topics: Acetamides; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Daptomycin; Debridement; Diabetic Foot; Drug Resistance, Microbial; Female; Foot Ulcer; Glycopeptides; Humans; Leg Ulcer; Linezolid; Lipoglycopeptides; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Wound Healing

2004
Current and new antimicrobial agents.
    American heart journal, 2004, Volume: 147, Issue:4

    Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Linezolid; Lipoglycopeptides; Methicillin Resistance; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Virginiamycin

2004
Update on prevalence and treatment of methicillin-resistant Staphylococcus aureus infections.
    Expert review of anti-infective therapy, 2007, Volume: 5, Issue:6

    Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Clindamycin; Daptomycin; Doxycycline; Folic Acid Antagonists; Global Health; Glycopeptides; Humans; Linezolid; Lipoglycopeptides; Methicillin; Methicillin Resistance; Minocycline; Oxazolidinones; Prevalence; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Teicoplanin; Tigecycline; Trimethoprim; Vancomycin

2007
Assessment by time-kill methodology of the synergistic effects of oritavancin in combination with other antimicrobial agents against Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10

    Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Drug Synergism; Fluoroquinolones; Gentamicins; Glycopeptides; Humans; Linezolid; Lipoglycopeptides; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Oxazolidinones; Polysorbates; Quinolines; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Surface-Active Agents; Vancomycin Resistance

2008
In vitro activities of oritavancin and comparators against meticillin-resistant Staphylococcus aureus (MRSA) isolates harbouring the novel mecC gene.
    International journal of antimicrobial agents, 2014, Volume: 44, Issue:1

    Topics: Acetamides; Anti-Bacterial Agents; Bacterial Proteins; Daptomycin; Gene Expression; Glycopeptides; Linezolid; Lipoglycopeptides; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microbial Viability; Oxazolidinones; Vancomycin

2014
chemdatabank.com